Related Experiment Video
Updated: Jun 20, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Robust pacemaking in substantia nigra dopaminergic neurons
Jaime N Guzman1, Javier Sánchez-Padilla, C Savio Chan
1Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Summary
Dopaminergic neurons
Area of Science:
- Neuroscience
- Neurophysiology
Background:
- Dopaminergic neurons in the substantia nigra pars compacta are crucial pacemakers.
- Somatodendritic L-type Ca2+ channels were traditionally considered essential for this pacemaking activity.
Purpose of the Study:
- To investigate the necessity of L-type Ca2+ channels for the autonomous pacemaking of dopaminergic neurons.
- To explore the role of these channels in supporting pacemaking under challenging conditions.
Main Methods:
- Utilized optical and electrophysiological techniques in brain slices.
- Employed L-type Ca2+ channel antagonism and intracellular calcium buffering.
- Conducted computational simulations to model pacemaking mechanisms.
Main Results:
- Blocking L-type Ca2+ channels eliminated dendritic Ca2+ oscillations but did not affect autonomous pacemaking.
- Intracellular calcium buffering had minimal impact on the pacemaking rate.
- L-type channels were found to support pacemaking when challenged by cationic channel blockers.
Conclusions:
- Autonomous pacemaking of dopaminergic neurons is independent of L-type Ca2+ channels.
- The multichannel nature of the pacemaking process contributes to its robustness.
- This finding offers insights into potential therapeutic strategies for Parkinson's disease, suggesting L-type Ca2+ channel modulators could offer neuroprotection without impairing neuronal function.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...